Dictionary.com
Thesaurus.com

muscular dystrophy

American  

noun

Pathology.
  1. a hereditary disease characterized by gradual wasting of the muscles with replacement by scar tissue and fat, sometimes also affecting the heart.


muscular dystrophy British  

noun

  1. a genetic disease characterized by progressive deterioration and wasting of muscle fibres, causing difficulty in walking

"Collins English Dictionary — Complete & Unabridged" 2012 Digital Edition © William Collins Sons & Co. Ltd. 1979, 1986 © HarperCollins Publishers 1998, 2000, 2003, 2005, 2006, 2007, 2009, 2012

muscular dystrophy Scientific  
/ mŭskyə-lərdĭstrə-fē /
  1. Any of a group of inherited progressive muscle disorders caused by a defect in one or more genes that control muscle function and characterized by gradual irreversible wasting of skeletal muscle.


muscular dystrophy Cultural  
  1. A hereditary disease in which the muscles progressively waste away. The disease can be potentially treated through gene therapy.


Etymology

Origin of muscular dystrophy

First recorded in 1865–70

Example Sentences

Examples are provided to illustrate real-world usage of words in context. Any opinions expressed do not reflect the views of Dictionary.com.

As well as raising money for a home, the family also want to their efforts to help other families in a similar situation, and raise awareness of Duchenne muscular dystrophy.

From BBC

A sudden muscle tear from a sports injury differs greatly from the slow decline in muscle strength seen in conditions such as muscular dystrophy.

From Science Daily

It has tumbled amid a Food and Drug Administration inquiry into Elevidys, one of the gene therapies targeting Duchenne muscular dystrophy, after two people who took the treatment died from liver failure.

From Barron's

It came after the biotechnology company disclosed disappointing trial data for two treatments for Duchenne muscular dystrophy, raising questions about how long it will take regulators to approve a key drug.

From Barron's

The company is developing experimental drugs based on the technology to treat forms of muscular dystrophy, a multibillion-dollar market.

From The Wall Street Journal